Channeling: a new class of dissolution in complex porous media

The current conceptual model of mineral dissolution in porous media is comprised of three dissolution patterns (wormhole, compact, and uniform) - or regimes - that develop depending on the relative dominance of flow, diffusion, and reaction rate. Here, we examine the evolution of pore structure during acid injection using numerical simulations on two porous media structures of increasing complexity. We examine the boundaries between regimes and characterise the existence of a forth regime called channeling, where already existing fast flow pathways are preferentially widened by dissolution. Channeling occurs in cases where the distribution in pore throat size results in orders of magnitude differences in flow rate for different flow pathways. This focusing of dissolution along only dominant flow paths induces an immediate, large change in permeability with a comparatively small change in porosity, resulting in a porosity-permeability relationship unlike any that has been previously seen. This work demonstrates that our current conceptual model of dissolution regimes must be modified to include channeling for accurate predictions of dissolution in applications such as geologic carbon storage and geothermal energy production

Experimental investigation of solubility trapping in 3D printed micromodels

Understanding interfacial mass transfer during dissolution of gas in a liquid is vital for optimising large-scale carbon capture and storage operations. While the dissolution of CO2 bubbles in reservoir brine is a crucial mechanism towards safe CO2 storage, it is a process that occurs at the pore-scale and is not yet fully understood. Direct numerical simulation (DNS) models describing this type of dissolution exist and have been validated with semi-analytical models on simple cases like a rising bubble in a liquid column. However, DNS models have not been experimentally validated for more complicated scenarios such as dissolution of trapped CO2 bubbles in pore geometries where there are few experimental datasets. In this work we present an experimental and numerical study of trapping and dissolution of CO2 bubbles in 3D printed micromodel geometries. We use 3D printing technology to generate three different geometries, a single cavity geometry, a triple cavity geometry and a multiple channel geometry. In order to investigate the repeatability of the trapping and dissolution experimental results, each geometry is printed three times and three identical experiments are performed for each geometry. The experiments are performed at low capillary number representative of flow during CO2 storage applications. DNS simulations are then performed and compared with the experimental results. Our results show experimental reproducibility and consistency in terms of CO2 trapping and the CO2 dissolution process. At such low capillary number, our numerical simulator cannot model the process accurately due to parasitic currents and the strong time step constraints associated with capillary waves. However, we show that, for the single and triple cavity geometry

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

Introduction: The multiorgan impact of moderate to severe coronavirus infections in the post-acute phase is still poorly understood. We aimed to evaluate the excess burden of multiorgan abnormalities after hospitalisation with COVID-19, evaluate their determinants, and explore associations with patient-related outcome measures. Methods: In a prospective, UK-wide, multicentre MRI follow-up study (C-MORE), adults (aged ≥18 years) discharged from hospital following COVID-19 who were included in Tier 2 of the Post-hospitalisation COVID-19 study (PHOSP-COVID) and contemporary controls with no evidence of previous COVID-19 (SARS-CoV-2 nucleocapsid antibody negative) underwent multiorgan MRI (lungs, heart, brain, liver, and kidneys) with quantitative and qualitative assessment of images and clinical adjudication when relevant. Individuals with end-stage renal failure or contraindications to MRI were excluded. Participants also underwent detailed recording of symptoms, and physiological and biochemical tests. The primary outcome was the excess burden of multiorgan abnormalities (two or more organs) relative to controls, with further adjustments for potential confounders. The C-MORE study is ongoing and is registered with ClinicalTrials.gov, NCT04510025. Findings: Of 2710 participants in Tier 2 of PHOSP-COVID, 531 were recruited across 13 UK-wide C-MORE sites. After exclusions, 259 C-MORE patients (mean age 57 years [SD 12]; 158 [61%] male and 101 [39%] female) who were discharged from hospital with PCR-confirmed or clinically diagnosed COVID-19 between March 1, 2020, and Nov 1, 2021, and 52 non-COVID-19 controls from the community (mean age 49 years [SD 14]; 30 [58%] male and 22 [42%] female) were included in the analysis. Patients were assessed at a median of 5·0 months (IQR 4·2–6·3) after hospital discharge. Compared with non-COVID-19 controls, patients were older, living with more obesity, and had more comorbidities. Multiorgan abnormalities on MRI were more frequent in patients than in controls (157 [61%] of 259 vs 14 [27%] of 52; p<0·0001) and independently associated with COVID-19 status (odds ratio [OR] 2·9 [95% CI 1·5–5·8]; padjusted=0·0023) after adjusting for relevant confounders. Compared with controls, patients were more likely to have MRI evidence of lung abnormalities (p=0·0001; parenchymal abnormalities), brain abnormalities (p<0·0001; more white matter hyperintensities and regional brain volume reduction), and kidney abnormalities (p=0·014; lower medullary T1 and loss of corticomedullary differentiation), whereas cardiac and liver MRI abnormalities were similar between patients and controls. Patients with multiorgan abnormalities were older (difference in mean age 7 years [95% CI 4–10]; mean age of 59·8 years [SD 11·7] with multiorgan abnormalities vs mean age of 52·8 years [11·9] without multiorgan abnormalities; p<0·0001), more likely to have three or more comorbidities (OR 2·47 [1·32–4·82]; padjusted=0·0059), and more likely to have a more severe acute infection (acute CRP >5mg/L, OR 3·55 [1·23–11·88]; padjusted=0·025) than those without multiorgan abnormalities. Presence of lung MRI abnormalities was associated with a two-fold higher risk of chest tightness, and multiorgan MRI abnormalities were associated with severe and very severe persistent physical and mental health impairment (PHOSP-COVID symptom clusters) after hospitalisation. Interpretation: After hospitalisation for COVID-19, people are at risk of multiorgan abnormalities in the medium term. Our findings emphasise the need for proactive multidisciplinary care pathways, with the potential for imaging to guide surveillance frequency and therapeutic stratification